Hiroo Takeda

1.0k total citations
30 papers, 863 citations indexed

About

Hiroo Takeda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Urology. According to data from OpenAlex, Hiroo Takeda has authored 30 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Urology. Recurrent topics in Hiroo Takeda's work include Urinary Bladder and Prostate Research (7 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Hiroo Takeda is often cited by papers focused on Urinary Bladder and Prostate Research (7 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). Hiroo Takeda collaborates with scholars based in Japan, Sweden and United States. Hiroo Takeda's co-authors include Masuo Akahane, Yoshinobu Yamazaki, Yasuhiko Igawa, Osamu Nishizawa, Yukiyoshi Ajisawa, Karl‐Erik Andersson, Satoshi Akahane, Kohichi Hayakawa, Takehisa Yoneyama and Hiroshi Miyata and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hiroo Takeda

30 papers receiving 833 citations

Peers

Hiroo Takeda
Patrizia Beneforti Italy
Alex Tong‐Long Lin Taiwan
Anita Mannikarottu United States
Philippe Cammisotto Canada
Robert M. Levin United States
Fikri Ak Türkiye
Shiva M. Nair Canada
Marina C. Calixto Brazil
Carolina Sollon Brazil
Xiaolin Deng China
Patrizia Beneforti Italy
Hiroo Takeda
Citations per year, relative to Hiroo Takeda Hiroo Takeda (= 1×) peers Patrizia Beneforti

Countries citing papers authored by Hiroo Takeda

Since Specialization
Citations

This map shows the geographic impact of Hiroo Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroo Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroo Takeda more than expected).

Fields of papers citing papers by Hiroo Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroo Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroo Takeda. The network helps show where Hiroo Takeda may publish in the future.

Co-authorship network of co-authors of Hiroo Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroo Takeda. A scholar is included among the top collaborators of Hiroo Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroo Takeda. Hiroo Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Kaoru, et al.. (2020). Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P‐Glycoprotein Inhibitor (Itraconazole). The Journal of Clinical Pharmacology. 60(10). 1314–1323. 7 indexed citations
2.
3.
Harada, Hiroshi, et al.. (2019). Quantitative Evaluation of Reactivity and Toxicity of Acyl Glucuronides by [35S]Cysteine Trapping. Chemical Research in Toxicology. 32(10). 1955–1964. 8 indexed citations
4.
Hayashi, T., et al.. (2017). Longitudinal analysis of motor symptoms and histopathology in woozy mice, a model of cerebellar ataxia. Neuroreport. 28(13). 779–787. 6 indexed citations
5.
Tatemichi, Satoshi, et al.. (2017). PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure. PLoS ONE. 12(7). e0180430–e0180430. 11 indexed citations
6.
Inoue, Toshihiro, Masaaki Takemura, Yoshikazu Fujimori, et al.. (2017). Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation. European Journal of Pharmacology. 806. 25–31. 39 indexed citations
7.
8.
Kobayashi, Jun’ichi, Tomonaga Ozawa, Hiroo Takeda, et al.. (2016). Synthesis and optimization of novel α-phenylglycinamides as selective TRPM8 antagonists. Bioorganic & Medicinal Chemistry. 25(2). 727–742. 13 indexed citations
9.
Takeda, Hiroo, et al.. (2010). KTO-7924, a Beta3-adrenergic Receptor Agonist, Reduces Hyperglycemia, and Protects Beta-cells in the Islets of Langerhans of db/db Mice. Endocrine Research. 35(4). 174–182. 3 indexed citations
10.
Takeda, Hiroo, et al.. (2005). Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism. 54(8). 995–1001. 71 indexed citations
11.
Takeda, Hiroo, et al.. (2005). Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a β3-adrenoceptor agonist. European Journal of Pharmacology. 518(1). 71–76. 32 indexed citations
12.
Takeda, Hiroo, Yoshinobu Yamazaki, Yasuhiko Igawa, et al.. (2002). Effects of β3‐adrenoceptor stimulation on prostaglandin E2–induced bladder hyperactivity and on the cardiovascular system in conscious rats. Neurourology and Urodynamics. 21(6). 558–565. 58 indexed citations
13.
Takeda, Hiroo, Yoshinobu Yamazaki, Masuo Akahane, et al.. (2002). Characterization of β-Adrenoceptor Subtype in Bladder Smooth Muscle in Cynomolgus Monkey. The Japanese Journal of Pharmacology. 88(1). 108–113. 22 indexed citations
14.
Takeda, Hiroo, Yoshinobu Yamazaki, Masuo Akahane, et al.. (2000). Role of the β3-Adrenoceptor in Urine Storage in the Rat: Comparison between the Selective β3-Adrenoceptor Agonist, CL316,243, and Various Smooth Muscle Relaxants. Journal of Pharmacology and Experimental Therapeutics. 293(3). 939–945. 33 indexed citations
15.
Takeda, Hiroo, Yasuhiko Igawa, Yoshimitsu Komatsu, et al.. (2000). Characterization of β-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo. European Journal of Pharmacology. 403(1-2). 147–155. 16 indexed citations
16.
Igawa, Yasuhiko, Yoshinobu Yamazaki, Hiroo Takeda, et al.. (1999). Functional and molecular biological evidence for a possible β3‐adrenoceptor in the human detrusor muscle. British Journal of Pharmacology. 126(3). 819–825. 190 indexed citations
17.
Yamazaki, Yoshinobu, Hiroo Takeda, Masuo Akahane, et al.. (1998). Species differences in the distribution of β‐adrenoceptor subtypes in bladder smooth muscle. British Journal of Pharmacology. 124(3). 593–599. 91 indexed citations
18.
Yamazaki, Yoshinobu, Masuo Akahane, Mamoru Kobayashi, Hiroo Takeda, & Yukiyoshi Ajisawa. (1996). Effects of KSG-504, a New Cholecystokinin-A-Receptor Antagonist, on Pancreatic Exocrine and Endocrine Secretions in Rats. The Japanese Journal of Pharmacology. 70(2). 183–190. 2 indexed citations
19.
Yamazaki, Yoshinobu, Kazuhiko Shinagawa, Hiroo Takeda, et al.. (1995). Cholecystokinin-A Specific Antagonism of KSG-504 to Cholecystokinin Receptor Binding and Pancreatic Secretion in Mammals. The Japanese Journal of Pharmacology. 69(4). 367–374. 1 indexed citations
20.
Doteuchi, Masami & Hiroo Takeda. (1978). Adrenergic innervation and contractile activity of the mesotubarium superius of the rabbit oviduct. Reproduction. 52(2). 213–219. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Beneforti Breakdown of academic impact, for papers by Alex Tong‐Long Lin Breakdown of academic impact, for papers by Anita Mannikarottu Breakdown of academic impact, for papers by Philippe Cammisotto Breakdown of academic impact, for papers by Robert M. Levin Breakdown of academic impact, for papers by Fikri Ak Breakdown of academic impact, for papers by Shiva M. Nair Breakdown of academic impact, for papers by Marina C. Calixto Breakdown of academic impact, for papers by Carolina Sollon Breakdown of academic impact, for papers by Xiaolin Deng
Rankless by CCL
2026